NCT05933135View on ClinicalTrials.gov

Factor XIII Activity in Gastrointestinal Bleedings

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Gastro Intestinal Bleeding
Interventions
DRUG

Factor XIII Injection

Patients could have had an Factor XIII Injection in clinical routine

Trial Locations (1)

8036

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT05933135 - Factor XIII Activity in Gastrointestinal Bleedings | Biotech Hunter | Biotech Hunter